Scott T. Rottinghaus, Chief Medical Officer: Enanta Pharmaceuticals ENTA Sell · Filed 24/07/15

Trade details

Type: Insider sale
Amount: $64,785.93
Shares · price: 4,299 sh · $15.07 a share
Held after: 23,988 sh
Stock: Enanta Pharmaceuticals ENTA
Person: Scott T. RottinghausChief Medical Officer
Trade date: 24/07/11
Filed: 24/07/15
Days to filing: 4 days

Sold 15.2% of holdings

Share of holding sold: 15.2%

Enanta Pharmaceuticals trades, last 26 weeks

What else happened in Enanta Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/06/11~24/08/10

Scott T. Rottinghaus's recent trades

Scott T. RottinghausChief Medical Officer
SellEnanta Pharmaceuticals
Sell
Enanta Pharmaceuticals
ENTA
$11.4K
798 sh
$11.4K
Filed 25/12/05
Traded 25/12/05
Scott T. RottinghausChief Medical Officer
Sell10b5-1 planEnanta Pharmaceuticals
Sell10b5-1 plan
Enanta Pharmaceuticals
ENTA
$6,980
866 sh
$6,980
Filed 24/12/10
Traded 24/12/06
Scott T. RottinghausChief Medical Officer
Sell10b5-1 planEnanta Pharmaceuticals
Sell10b5-1 plan
Enanta Pharmaceuticals
ENTA
$91.8K
5,375 sh
$91.8K
Filed 24/07/15
Traded 24/07/15
Scott T. RottinghausChief Medical Officer
Sell10b5-1 planEnanta Pharmaceuticals
Sell10b5-1 plan
Enanta Pharmaceuticals
ENTA
$34.2K
2,271 sh
$34.2K
Filed 24/07/15
Traded 24/07/12
Scott T. RottinghausSr. VP & CMO
SellEnanta Pharmaceuticals
Sell
Enanta Pharmaceuticals
ENTA
$5,142
534 sh
$5,142
Filed 23/12/06
Traded 23/12/05